The Michael J. Fox Foundation (MJFF) is accepting pre-proposals for funding of Parkinson’s disease research, including from biotech and pharmaceutical companies. Of the more than $525 million to research programs MJFF has funded since 2000, $110 million in non-dilutive capital has been allocated to industry projects.
The Foundation supports research toward Parkinson’s target advancement, therapeutic development (symptomatic and disease-modifying), and improved biomarkers and outcome measures. The pre-proposal deadline is October 28.
Visit https://www.michaeljfox.org/research/apply-for-grant.html to learn more and download application instructions.